Mechanical Ventilation in Interstitial Lung Disease
Risk Factors for Mortality in Patients With Interstitial Lung Disease Receiving Mechanical Ventilation: A Retrospective, Observational Cohort Study
1 other identifier
observational
94
0 countries
N/A
Brief Summary
To identify risk factors for mortality in patients with interstitial lung disease receiving mechanical ventilation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2011
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2017
CompletedFirst Submitted
Initial submission to the registry
January 7, 2018
CompletedFirst Posted
Study publicly available on registry
January 30, 2018
CompletedJanuary 30, 2018
January 1, 2018
7 years
January 7, 2018
January 29, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
ICU Mortality
7 years
Secondary Outcomes (3)
Hospital mortality
7 years
Noninvasive mechanical ventilation failure
7 years
Invasive mechanical ventilation failure
7 years
Interventions
Noninvasive and/or invasive mechanical ventilation were performed when patients had respiratory failure.
Eligibility Criteria
Patients were diagnosed as interstitial lung disease and received mechanical ventilation.
You may qualify if:
- They were clearly diagnosed as interstitial lung disease in hospital;
- They had progressive worsening of dyspnea and their oxygenation indexes were less than 300 in ICU;
- They received at least 48 hours of mechanical ventilation after being admitted into ICU.
You may not qualify if:
- We excluded patients who were admitted into ICU because of postoperative monitoring.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Zujin Luo, MD
Beijing Chao Yang Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Attending physician
Study Record Dates
First Submitted
January 7, 2018
First Posted
January 30, 2018
Study Start
January 1, 2011
Primary Completion
December 31, 2017
Study Completion
December 31, 2017
Last Updated
January 30, 2018
Record last verified: 2018-01
Data Sharing
- IPD Sharing
- Will not share